Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  • Michael Donahoe,
  • Vincent G. Valentine,
  • Nydia Chien,
  • Kevin F. Gibson,
  • Jay S. Raval,
  • Melissa Saul,
  • Jianmin Xue,
  • Yingze Zhang,
  • Steven R. Duncan
  • Article
  • Metrics
  • Comments
  • Media Coverage

In the penultimate sentence of the Results section of the Abstract, the plus sign should be a plus-or-minus sign. The correct sentence is: One-year survival of trial subjects was 46±15% vs. 0% among historical controls.

In Table 2, spaces are missing before the acronym “PEEP” in the “Pre-Rx O2” and “Post-Rx O2” columns. Please see the correct Table 2 here.

thumbnail
Download:
Table 2. Individual Treatment Outcomes.

https://doi.org/10.1371/journal.pone.0133684.t001

Reference

  1. 1. Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, et al. (2015) Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis. PLoS ONE 10(6): e0127771. pmid:26083430

Citation: Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, et al. (2015) Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis. PLoS ONE 10(7): e0133684. https://doi.org/10.1371/journal.pone.0133684

Published: July 20, 2015

Copyright: © 2015 Donahoe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited